BioWorld MedTech

Sep. 3, 2010

Spine market facing growth challenges, analyst says

Right now it's better to be a smaller, well-capitalized spine company with a broad product line than a larger spine company, according to one analyst who covers the space. (Medical Device Daily) Read More

Study shows Cepheid's test is an 'Xpert' in diagnosing TB

SYNTAX creates common ground for coronary risk assessment

Washington roundup: Alphatec warned after taking back some manufacturing work

Holiday notice

Med-Tech Notes

Deals roundup: Erba buys most of Ivax shares for $15M

MDD's food for med-tech thought

Agreements/contracts: LifeCell to distribute Novadaq's SPY imaging

Courts report: Allergan to pay $600M to settle Botox-related charges

Financings roundup: AHP discloses results of self-tender offer

Restructuring roundup: Angeion restructures board and names two new officers

People in the News

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 3, 2025.

Today's news in brief

Briefs

BioWorld MedTech briefs for Jan. 30, 2026.

Centessa’s CNT-9982 shows promise for MDD

BioWorld Science

Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...

First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

BioWorld Science

Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...

Illustration of brain with neuron receptor

5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

BioWorld Science

Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...